Skip to main content
. 2017 Jan 16;3:16046. doi: 10.1038/cddiscovery.2016.46

Figure 1.

Figure 1

Chemical structures of selected monovalent and bivalent IAP antagonists and their ability to induce the degradation of GFP-cIAP1. (a) Covalent attachment at the P4 position of monovalent IAP antagonists increased their ability to induce degradation of GFP-cIAP1. P1, P2, P3 and P4: amino acid positions. (b) The monovalent IAP antagonist, M4, was ~20-fold more potent than B1 in the GFP-cIAP1 degradation assay. Results are mean±S.E.